See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← LBIRD page
XStocksXray
Market X-Ray report · 23 October 2026

Lumibird SA (LBIRD)

Euronext Paris · France · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 23.10
52-week range18.75 – 28.70
Return, 1 month / 3 months−6.5% / −15.4%
Return, 1 year / 3 years+15.6% / +73.9%
TrendBelow its 200-day average
RSI (14)45
Volatility (1 year)40.3%
Worst drawdown (1 year)-23.2%
Average daily value traded0.70M EUR
Dividend yield1.6%

Market X-Ray price-based

60/ 100 · High confidence · ahead of 65% of stocks on this exchange
Trend70
Momentum60
Stability (higher is calmer)62
Liquidity76
Income8

Five-year price chart navy: price · brown: 200-day average

5.3811.4917.6023.7029.812021-112023-022024-052025-082026-10

About the company

Lumibird is a French laser technology company based in Lannion, Brittany. It designs and manufactures solid-state lasers, fibre lasers and laser diodes, along with related optical components and lidar systems. Its customers include industrial manufacturers, scientific laboratories, medical device makers and defence organisations, who use the lasers for materials processing, sensing, instrumentation and eye treatments. The group also provides laser systems for environmental and range-finding applications.

On this site Lumibird SA appears as a stock on the Euronext Paris (France), code LBIRD, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Lumibird SA (LBIRD) trades on the Euronext Paris in France. It last closed at EUR 23.10 on 23 October 2026.

Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 221 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 15.6% and over the last three months it fell 15.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Lumibird SA (LBIRD)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend70 · FairMixed trend against its averages.
Above 200-day average-3.7%
From 52-week high-18.9%
Momentum60 · FairTypical recent returns for this exchange.
3-month return-15.4%
6-month return-4.2%
12-month return, skipping the last month23.6%
Stability (higher is calmer)62 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)40.3%
Worst drawdown, 1 year (smaller is calmer)-23.2%
Liquidity76 · StrongTrades actively.
Average daily value traded0.70M EUR
Zero-volume days0.0%
Income8 · WeakDividend is small or irregular.
Dividend yield1.6%
Years with dividends1

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week+2.2%
1 month−6.5%
3 months−15.4%
6 months−4.2%
1 year+15.6%
3 years+73.9%
5 years+14.5%

Signals

50-day / 200-day average24.57 / 23.99
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.77

Technical summary

DailyBearish4 bullish · 4 neutral · 8 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

Recent dividends

Ex-dividend dateAmount per share
18 May 2026EUR 0.3738

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026